This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Nu Skin Shows Why You're a Fool For Shorting Herbalife

NEW YORK (TheStreet) -- Good news! Nu Skin Enterprises (NUS - Get Report) is only getting fined.

If you're short Herbalife (HLF), you better take a close look at Nu Skinand what happens when a stock priced for destruction receives a stay of execution.

Nu Skin, the network marketing health care product maker, said China's Administration of Industry and Commerce will only hit Nu Skin with $540,000 in fines for unregistered direct sales and product claims lacking sufficient evidence to support stated benefits.

The market heard this and saw a significant victory because China could've barred the company from ever selling its products there again.

Nu Skin shares soared over 30% in pre-market trading and now are up 19% to $89. Nu Skin Enterprises voluntarily suspended business promotional meetings and new applications for sales representatives earlier this year and hasn't resumed recruiting pending direction from Chinese regulators.


Nu Skin Enterprises' short-seller blood bath on Monday is nothing compared to what Herbalife investors will face if it receives a comparable Chinese resolution. Only 4.7% of Nu Skin Enterprises shares are shorted compared to neck-tightening 24% short interest for Herbalife.

For Herbalife investors, an announced slap on the wrist could send shares 50% higher before the opening bell. I warned investors that shorting Herbalife is full of peril offering little chance to profit. Maybe if you're skilled at active day trading a profit can be squeezed out of trading options, but if you buy and hold put options, you have a negative expectation in my view.

I also posted a Real Money Pro trade idea that included selling the August $40 put before the market opened on Friday. It's fantastic that it turned out to be the high of the day, but more importantly is it places you in a position to receive the best of it when others panic.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
NUS $39.54 2.10%
AAPL $123.28 0.42%
FB $95.36 1.30%
GOOG $628.28 0.16%
TSLA $264.79 4.70%

Markets

Chart of I:DJI
DOW 17,628.63 +188.04 1.08%
S&P 500 2,092.94 +25.30 1.22%
NASDAQ 5,085.4820 +45.7060 0.91%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs